Standard Tubal Ligation Versus Salpingectomy for Sterilization at the Time of Cesarean Delivery

April 7, 2018 updated by: Kate Pettit, MD, University of Virginia

A Randomized Controlled Trial of Standard Tubal Ligation Versus Salpingectomy for Sterilization at the Time of Cesarean Delivery

The objective of this study is to evaluate the feasibility and safety of salpingectomy versus standard tubal ligation in women undergoing surgical sterilization at the time of a planned cesarean delivery. Salpingectomy is currently being investigated as a potential strategy for ovarian cancer prevention. While this procedure is currently performed during hysterectomies, its feasibility at the time of cesarean delivery is not well established.

This randomized, prospective clinical trial will compare the two sterilization methods to demonstrate that salpingectomy compared with standard tubal ligation at the time of cesarean delivery will not result in increased operative time, blood loss or other complications. This study is necessary to promote salpingectomy as a standard sterilization method during cesarean deliveries.

Study Overview

Study Type

Interventional

Enrollment (Actual)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Virginia
      • Charlottesville, Virginia, United States, 22908
        • University of Virginia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Subjects must have planned cesarean delivery and desire sterilization
  • Subjects must be able to read and provide written informed consent
  • Subjects must be English or Spanish speaking

Exclusion Criteria:

  • Subjects with known hereditary cancer syndromes
  • Subjects with a history of prior tubal surgery
  • Subjects with a placenta accreta
  • Subjects undergoing trial of labor after cesarean delivery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Control
Tubal sterilization will be performed by standard tubal ligation, either Parkland or Pomeroy technique, at the time of cesarean section
Standard tubal ligation by either Parkland or Pomeroy technique will be performed at cesarean section
Experimental: Experimental
Tubal sterilization will be performed by bilateral salpingectomy using a ligasure device at the time of cesarean section.
Bilateral salpingectomy will be performed instead of standard tubal ligation as sterilization during cesarean section.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time of tubal ligation
Time Frame: at time of procedure
Primary outcome will be the time it takes to complete the sterilization procedure
at time of procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total procedure time
Time Frame: at time of procedure
The total time it takes to complete the cesarean plus sterilization procedure
at time of procedure
Estimated blood loss
Time Frame: at time of procedure
Estimated blood loss for the entire procedure
at time of procedure
Rate of aborted procedures
Time Frame: at time of procedure
Inability to complete bilateral salpingectomy in the experimental arm
at time of procedure

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reoperation rate
Time Frame: within 6 weeks
Rate of reoperation within 6 weeks
within 6 weeks
Length of stay
Time Frame: within 1008 hours
Length of stay in hours
within 1008 hours
Readmission rate
Time Frame: within 6 weeks
Rate of readmission within 6 weeks
within 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kate' Pettit, MD, University of Virginia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2017

Primary Completion (Actual)

March 5, 2018

Study Completion (Actual)

March 5, 2018

Study Registration Dates

First Submitted

January 13, 2017

First Submitted That Met QC Criteria

January 19, 2017

First Posted (Estimate)

January 23, 2017

Study Record Updates

Last Update Posted (Actual)

April 10, 2018

Last Update Submitted That Met QC Criteria

April 7, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 19517 (Other Identifier: City of Hope Comprehensive Cancer Center)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Method of Tubal Ligation at the Time of Cesarean Section

Clinical Trials on Tubal ligation

3
Subscribe